155 / 330
155
19–22 APRIL, 2017, BARCELONA, SPAIN
4. Our fistula rate of 28% may seem high, but is in line with reports published in literature- Pippi-
Salle J Pediatr Urol, 2015- S1477.
On the strength of our experience, we would encourage surgeons to try single stage procedures
more often, and to use buccal mucosa even in primary operations.
S14-10 (P without presentation)
CAN FIBRIN GLUE BE A USEFUL ADJUNCT TO SURGICAL
MANAGEMENT OF RECURRENT FISTULA POST
HYPOSPADIAS SURGERY?
Ahmed HASSAN
Cairo university specialized pediatric hospital CUSPH. Bani suif general hospital, Pediatric surgery unit., Bai Suif,
EGYPT
PURPOSE
To evaluate the efficacy of fibrin glue as a sealant agent in repair of recurrent urethro-cutaneous
fistula post hypospadias surgery.
MATERIAL AND METHODS
Over the period from Oct. 2014 to Dec. 2015, 20 patients in the pediatric age group with history of
hypospadias surgery and at least two failed attempts of fistula repair operations leading to recurrent
urethrocutaneous fistula. 17 patients underwent surgical repair using fibrin glue& the other 3 pa-
tients, two of them were candidates for repeated dilatation prior to surgery due to meatal stenosis
and the other one needed diverticulectomy and urinary diversion.
For those underwent repair using fibrin glue, during the operation, fibrin glue was applied over the
suture lines and beneath the skin. A urethral catheter was kept in place for 5-7 days. Follow up
ranged from 6 to 14 months (mean 10 months).
RESULTS
fourteen patients had an uneventful postoperative course. In one patient, partial wound dehiscence
occurred and urethra remained intact, he recovered after 2 months with no further surgical interven-
tion. Accidentally early cath. removal occurred in 2 cases with no subsequent problem. No fistula
recurrence was reported during follow up period.
CONCLUSIONS
A fibrin glue as a sealant agent could be a useful adjunct to surgical management of patients after
multiple failed attempts of post hypospadias surgery urethro-cutanouse fistula repair.
Moreover, trials concerning using single donor fibrin glue should be considered.